Skip to content

XIENCE Sierra™ 1550275-08Recalls & reported problems

Abbott Vascular Inc. · XIENCE Sierra™ Everolimus Eluting Coronary Stent System 2.75 mm x 08 mm / Rapid-Exchange · Class 3 · Implant

All models of XIENCE Sierra (56)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648227158), received between Dec 19, 2019 and Apr 23, 2021 — classified as 3 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3

Patient problems

  • Angina2
  • Stenosis2
  • High Blood Pressure/ Hypertension1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 23, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2019, THE PATIENT PRESENTED WITH A SEVERELY CALCIFIED, PROXIMAL CIRCUMFLEX (CX) CORONARY ARTERY WITH A CHRONIC TOTAL OCCLUSION AND 70% STENOSED LESION. PRE-DILATATION WAS PERFORMED AND A 2.75X8MM XIENCE SIERRA STENT (1550275-08, 8092641) WAS IMPLANTED IN THE PROXIMAL CX, WITHOUT A DEVICE ISSUE REPORTED. FOLLOWING, PRE-DILATATION WAS PERFORMED ON THE 2ND OBTUSE MARGINAL (OM) CORONARY ARTERY, 95% STENOSED LESION AND A 2.75X8MM XIENCE SIERRA STENT (1550250-08, 9020541) WAS IMPLANTED WITHOUT A DEVICE ISSUE REPORTED. ON (B)(6) 2021, THE PATIENT WAS HOSPITALIZED FOR CHEST PAIN. PER IMAGING, THE PROXIMAL CX WAS 90% STENOSED. AS TREATMENT, ANOTHER DRUG-ELUTING STENT WAS PLACED IN THE PROXIMAL CX. IN ADDITION, ANOTHER STENT WAS ALSO IMPLANTED IN THE 80% STENOSED PROXIMAL RIGHT CORONARY ARTERY LESION. PER PHYSICIAN, THERE WAS NO DEVICE MALFUNCTION AND THE EVENT WAS UNRELATED TO THE XIENCE DEVICE. THE EVENT RESOLVED WITHOUT SEQUELA. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.

    Patient problems: Angina; Stenosis

    MAUDE report 11716780 ↗
  • InjuryJun 18, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2020, A 2.75X08MM AND 2.75X18MM XIENCE SIERRA STENT WERE IMPLANTED WITHOUT A DEVICE ISSUE NOTED. ON (B)(6) 2020, THE PATIENT WAS ADMITTED TO THE HOSPITAL DUE TO HYPERTENSION. THE PATIENT WAS DISCHARGED HOME 4 DAYS LATER. THE DEVICE RELATIONSHIP TO THE EVENT IS UNKNOWN. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.

    Patient problems: High Blood Pressure/ Hypertension

    MAUDE report 10169438 ↗
  • InjuryDec 19, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT ID (B)(6). IT WAS REPORTED THAT ON (B)(6) 2019, THE PATIENT UNDERWENT A CORONARY PROCEDURE, TREATING A TARGET LESION IN THE CIRCUMFLEX (CX) ARTERY. A 2.75 X 8 MM XIENCE SIERRA STENT WAS IMPLANTED. ON (B)(6) 2019, THE PATIENT WAS SEEN FOR A FOLLOW UP VISIT AND REPORTED ANGINA. THE PATIENT¿S IMDUR MEDICATION DOSAGE WAS INCREASED. THE PATIENT CONDITION CONTINUES. NO ADDITIONAL INTERVENTION WAS PERFORMED. ON (B)(6) 2019, THE PATIENT UNDERWENT CORONARY ANGIOGRAPHY, DUE TO ONGOING CHEST PAIN. IN-STENT RESTENOSIS WAS NOTED IN THE TARGET LESION, AS WELL AS THE LEFT MAIN ARTERY. SURGICAL CONSULT WAS OBTAINED AND THE PATIENT UNDERWENT CORONARY ARTERY BYPASS GRAFT (CABG) ON (B)(6) 2019. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Angina; Stenosis

    MAUDE report 9492825 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page